Allogenic Stem Cell Transplantation Abrogates Negative Impact on Outcome of AML Patients with KMT2A Partial Tandem Duplication

Allogenic Stem Cell Transplantation Abrogates Negative Impact on Outcome of AML Patients with KMT2A Partial Tandem Duplication

Recently, a new subset of acute myeloid leukemia (AML) presenting a direct partial tandem duplication (PTD) of the <i>KMT2A</i> gene was described. The consequences of this alteration in terms of outcome and response to treatment remain unclear. We analyzed retrospectively a cohort of &l...

Full description

Bibliographic Details
Main Authors: Gabriel Antherieu, Audrey Bidet, Sarah Huet, Sandrine Hayette, Marina Migeon, Lisa Boureau, Pierre Sujobert, Xavier Thomas, Hervé Ghesquières, Arnaud Pigneux, Mael Heiblig
Format: Article
Language:English
Published: MDPI AG 2021-05-01
Series:Cancers
Subjects:
acute myeloid leukemia
KMT2A
transplantation
Online Access:https://www.mdpi.com/2072-6694/13/9/2272

Internet

https://www.mdpi.com/2072-6694/13/9/2272

Similar Items